ResMed Inc. (RMD)
Makes devices and software to help people breathe better and manage sleep apnea.
$203.08+0.04%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-27.3%
The outlook
ResMed trades at $203.08 with analyst consensus leaning Buy, though price momentum shows mixed signals relative to moving averages. The stock sits near its 52-week low end of the range, while the average analyst target sits roughly 22% above the current price.
What’s behind the score
Analyst consensusBuy — 2.4 avg of 15 analysts
Price trendMixed vs its moving averages
52-week range20% of the way from its 52-week low to high
Price targetAvg target +22% vs current price
Analyst price target
~12-month · 15 analysts$248.60average target+22.4% vs now
Now $203.08
Low $180.00High $325.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$29.46B
52-wk high
$293.81
52-wk low
$180.27
50-day avg
$198.69
200-day avg
$233.32
Trailing P/E
18.8